Victory Capital Management Inc Arvinas, Inc. Transaction History

Victory Capital Management Inc

  • $95.7 Billion
  • Q4 2024

A detailed history of Victory Capital Management Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 45,450 shares of ARVN stock, worth $849,915. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,450
Previous 46,520 2.3%
Holding current value
$849,915
Previous $1.15 Million 23.93%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
SELL
$17.83 - $28.04 $19,078 - $30,002
-1,070 Reduced 2.3%
45,450 $871,000
Q3 2024

Nov 05, 2024
SELL
$23.66 - $32.73 $174,894 - $241,940
-7,392 Reduced 13.71%
46,520 $1.15 Million
Q2 2024

Aug 05, 2024
BUY
$24.46 - $40.4 $365,041 - $602,929
14,924 Added 38.28%
53,912 $1.44 Million
Q1 2024

May 03, 2024
BUY
$36.38 - $52.31 $1.19 Million - $1.7 Million
32,582 Added 508.62%
38,988 $1.61 Million
Q4 2023

Feb 05, 2024
BUY
$14.19 - $42.33 $90,901 - $271,165
6,406 New
6,406 $263,000
Q3 2022

Nov 02, 2022
SELL
$41.87 - $57.99 $3,391 - $4,697
-81 Reduced 0.84%
9,573 $426,000
Q2 2022

Aug 01, 2022
BUY
$36.01 - $74.24 $46,668 - $96,215
1,296 Added 15.51%
9,654 $406,000
Q1 2022

May 04, 2022
SELL
$60.27 - $81.57 $221,914 - $300,340
-3,682 Reduced 30.58%
8,358 $459,000
Q4 2021

Feb 07, 2022
SELL
$65.85 - $96.21 $71,974 - $105,157
-1,093 Reduced 8.32%
12,040 $989,000
Q3 2021

Nov 02, 2021
BUY
$73.2 - $107.87 $188,416 - $277,657
2,574 Added 24.38%
13,133 $1.08 Million
Q2 2021

Aug 03, 2021
BUY
$60.45 - $84.26 $263,985 - $367,963
4,367 Added 70.53%
10,559 $813,000
Q1 2021

May 04, 2021
BUY
$58.19 - $91.37 $17,224 - $27,045
296 Added 5.02%
6,192 $409,000
Q4 2020

Feb 01, 2021
SELL
$20.19 - $84.93 $59,398 - $249,864
-2,942 Reduced 33.29%
5,896 $501,000
Q3 2020

Nov 09, 2020
SELL
$22.99 - $36.34 $128,123 - $202,522
-5,573 Reduced 38.67%
8,838 $209,000
Q2 2020

Aug 07, 2020
BUY
$29.88 - $56.74 $145,366 - $276,040
4,865 Added 50.96%
14,411 $483,000
Q1 2020

May 04, 2020
BUY
$33.0 - $54.5 $178,200 - $294,300
5,400 Added 130.25%
9,546 $385,000
Q4 2019

Feb 06, 2020
SELL
$15.39 - $44.38 $2,093 - $6,035
-136 Reduced 3.18%
4,146 $170,000
Q4 2019

Feb 04, 2020
BUY
$15.39 - $44.38 $38,136 - $109,973
2,478 Added 137.36%
4,282 $208,000
Q3 2019

Nov 12, 2019
BUY
$21.55 - $27.61 $38,876 - $49,808
1,804 New
1,804 $39,000

Others Institutions Holding ARVN

# of Institutions
228
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $995M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email